News - Stimdia Medical

Stimdia Medical Inc. Initiates FDA Approved IDE Pivotal Trial to Investigate Impact of Neuromuscular Stimulation on Mechanically Ventilated Patients – link 

October 2023 | News

Stimdia Medical Announces Close of Series B Equity Financing Round with Proceeds to be Used to Complete the Company’s Pivotal Study – link 

July 2022 | News

Stimdia Medical receives FDA breakthrough device designation for the pdSTIM™ System designed to facilitate weaning patients from mechanical ventilation – link

March 2021 | News

Results of PEPNS study published in Critical Care Medicine, official journal of the Society of Critical Care Medicine (SCCM) – link

May 2020 | News

Results of PEPNS study presented during the European Society of Intensive Care Medicine’s (ESICM) 32nd Annual Congress held in Berlin, Germany – link

September 2019 | News

Stimdia Medical reports completion of enrollment and follow-up for PEPNS study

February 2019 | News

Stimdia Medical reports successful completion of 30 day follow-up on first two patients enrolled into landmark PEPNS study

October 2018 | News

Stimdia Medical completes GLP chronic study for PEPNS System

March 2018 | News

Stimdia Medical receives 2nd Tranche for Series A1 Financing

March 2018 | News

Stimdia Medical receives 1st Tranche for Series A1 Financing

December 2017 | News

Stimdia Medical completes GLP acute phase study for PEPNS System

December 2017 | News

Stimdia Medical granted landmark foundational patent associated with electrical stimulation for preservation and restoration of diaphragm function

June 2017 | News

Stimdia Medical completes Series A Option 2x Financing

March 2017 | News

Andarta Medical changes name to Stimdia Medical

March 2016 | News

Andarta Medical closes Series A funding with world class investor syndicate Draper Triangle Ventures (Mr. Jay Katarinic), the University of Minnesota Discovery Capital Program (Mr. Russ Straate) and Industry Veteran Executive and Investor James Bullock

December 2015 | News